MRGPRE
gene geneOn this page
Also known as mrgE
Summary
MRGPRE (MAS related GPR family member E, HGNC:30694) is a protein-coding gene on chromosome 11p15.4, encoding Mas-related G-protein coupled receptor member E (Q86SM8). G protein-coupled receptor for L-tryptophanocholate (Trp-CA), an amino-acid-conjugated bile acid produced by the microbiome, which regulates glucose homeostasis.
Predicted to enable G protein-coupled receptor activity. Predicted to be involved in G protein-coupled receptor signaling pathway. Predicted to be located in membrane. Predicted to be active in plasma membrane.
Source: NCBI Gene 116534 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 31 total
- Druggable target: yes
- MANE Select transcript:
NM_001039165
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30694 |
| Approved symbol | MRGPRE |
| Name | MAS related GPR family member E |
| Location | 11p15.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | mrgE |
| Ensembl gene | ENSG00000184350 |
| Ensembl biotype | protein_coding |
| OMIM | 607232 |
| Entrez | 116534 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000389832
RefSeq mRNA: 1 — MANE Select: NM_001039165
NM_001039165
CCDS: CCDS41603
Canonical transcript exons
ENST00000389832 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001303728 | 3225030 | 3228860 |
| ENSE00001562442 | 3232141 | 3232417 |
Expression profiles
Bgee: expression breadth ubiquitous, 119 present calls, max score 92.12.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0833 / max 35.6319, expressed in 33 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 118288 | 0.0383 | 16 |
| 118286 | 0.0217 | 9 |
| 118290 | 0.0104 | 2 |
| 118289 | 0.0080 | 2 |
| 118287 | 0.0049 | 1 |
Top tissues by expression
242 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| dorsal root ganglion | UBERON:0000044 | 92.12 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 85.93 | gold quality |
| kidney epithelium | UBERON:0004819 | 74.97 | gold quality |
| pons | UBERON:0000988 | 74.46 | gold quality |
| vena cava | UBERON:0004087 | 66.32 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 64.17 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 62.42 | gold quality |
| islet of Langerhans | UBERON:0000006 | 61.62 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 61.44 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 61.09 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 60.98 | gold quality |
| quadriceps femoris | UBERON:0001377 | 60.88 | gold quality |
| vastus lateralis | UBERON:0001379 | 60.77 | gold quality |
| decidua | UBERON:0002450 | 59.84 | silver quality |
| medulla oblongata | UBERON:0001896 | 59.54 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 59.25 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 58.86 | gold quality |
| endocervix | UBERON:0000458 | 58.25 | gold quality |
| pylorus | UBERON:0001166 | 57.76 | gold quality |
| tibialis anterior | UBERON:0001385 | 56.90 | silver quality |
| apex of heart | UBERON:0002098 | 56.80 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 56.54 | gold quality |
| body of tongue | UBERON:0011876 | 56.54 | gold quality |
| cartilage tissue | UBERON:0002418 | 56.33 | gold quality |
| hypothalamus | UBERON:0001898 | 56.29 | gold quality |
| saphenous vein | UBERON:0007318 | 56.07 | gold quality |
| nipple | UBERON:0002030 | 56.04 | gold quality |
| mammalian vulva | UBERON:0000997 | 56.03 | silver quality |
| uterine cervix | UBERON:0000002 | 55.98 | gold quality |
| pericardium | UBERON:0002407 | 55.97 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Mrgpre | ENSMUSG00000048965 |
| rattus_norvegicus | Mrgpre | ENSRNOG00000065330 |
Paralogs (10): MAS1 (ENSG00000130368), MRGPRX1 (ENSG00000170255), MRGPRF (ENSG00000172935), MRGPRD (ENSG00000172938), GPR152 (ENSG00000175514), MRGPRX4 (ENSG00000179817), MRGPRX3 (ENSG00000179826), MRGPRG (ENSG00000182170), MRGPRX2 (ENSG00000183695), MAS1L (ENSG00000204687)
Protein
Protein identifiers
Mas-related G-protein coupled receptor member E — Q86SM8 (reviewed: Q86SM8)
Alternative names: G-protein coupled receptor 167
All UniProt accessions (2): Q86SM8, W4VSQ4
UniProt curated annotations — full annotation on UniProt →
Function. G protein-coupled receptor for L-tryptophanocholate (Trp-CA), an amino-acid-conjugated bile acid produced by the microbiome, which regulates glucose homeostasis. Expressed in enteroendocrine L cells of the gut epithelium: Trp-CA binding causes a conformation change that triggers signaling via G(s) G protein, mediating activation of adenylate cyclase activity. In addition to G(s), MRGPRE also associates with beta-arrestin-1 (ARRB1), promoting phosphorylation of ALDOA. Both G(s) and beta-arrestin-1 signaling pathways improves glucose tolerance by enhancing GLP-1 secretion.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family. Mas subfamily.
RefSeq proteins (1): NP_001034254* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR026230 | MRGPCRE | Family |
| IPR026234 | MRGPCRFAMILY | Family |
Pfam: PF00001
UniProt features (26 total): topological domain 8, transmembrane region 7, mutagenesis site 7, sequence variant 2, chain 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86SM8-F1 | 85.21 | 0.58 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 162–174
Mutagenesis-validated functional residues (7):
| Position | Phenotype |
|---|---|
| 99 | decreased g(s)-mediated signaling in response to trp-ca. |
| 103 | decreased g(s)-mediated signaling in response to trp-ca. abolished trp-ca-induced glp-1 secretion. |
| 107 | decreased g(s)-mediated signaling in response to trp-ca. abolished trp-ca-induced glp-1 secretion. |
| 232 | decreased g(s)-mediated signaling in response to trp-ca. |
| 233 | decreased g(s)-mediated signaling in response to trp-ca. |
| 251 | decreased g(s)-mediated signaling in response to trp-ca. |
| 261 | decreased g(s)-mediated signaling in response to trp-ca. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 89 (showing top):
GOBP_INSULIN_SECRETION, GOBP_CELLULAR_RESPONSE_TO_CARBOHYDRATE_STIMULUS, GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION, GOBP_REGULATION_OF_HORMONE_LEVELS, GOBP_HORMONE_TRANSPORT, GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, GOBP_CELL_CELL_SIGNALING, GOBP_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_POSITIVE_REGULATION_OF_INSULIN_SECRETION, GOBP_REGULATION_OF_PROTEIN_SECRETION, GOBP_REGULATION_OF_CELLULAR_LOCALIZATION, GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, GOBP_SECRETION, GOBP_POSITIVE_REGULATION_OF_HORMONE_SECRETION, GOBP_SIGNAL_RELEASE
GO Biological Process (7): intracellular glucose homeostasis (GO:0001678), cell surface receptor signaling pathway (GO:0007166), G protein-coupled receptor signaling pathway (GO:0007186), adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189), positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774), adenylate cyclase-activating G protein-coupled bile acid receptor signaling pathway (GO:0038184), signal transduction (GO:0007165)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), G protein-coupled bile acid receptor activity (GO:0038182)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| signal transduction | 2 |
| G protein-coupled receptor activity | 2 |
| glucose homeostasis | 1 |
| intracellular chemical homeostasis | 1 |
| adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1 |
| adenylate cyclase activator activity | 1 |
| positive regulation of insulin secretion | 1 |
| insulin secretion involved in cellular response to glucose stimulus | 1 |
| regulation of insulin secretion involved in cellular response to glucose stimulus | 1 |
| cell surface receptor signaling pathway | 1 |
| adenylate cyclase-activating G protein-coupled receptor signaling pathway | 1 |
| G protein-coupled bile acid receptor activity | 1 |
| bile acid signaling pathway | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| adenylate cyclase-activating G protein-coupled bile acid receptor signaling pathway | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
270 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRGPRE | NPFF | O15130 | 710 |
| MRGPRE | GPR139 | Q6DWJ6 | 481 |
| MRGPRE | GHRH | P01286 | 468 |
| MRGPRE | MRGPRD | Q8TDS7 | 452 |
| MRGPRE | STMND1 | H3BQB6 | 418 |
| MRGPRE | ZNF195 | O14628 | 398 |
| MRGPRE | OPN1SW | P03999 | 365 |
| MRGPRE | MORF4L2 | Q15014 | 358 |
| MRGPRE | GPR149 | Q86SP6 | 316 |
| MRGPRE | SAAL1 | Q96ER3 | 300 |
| MRGPRE | ANKDD1B | A6NHY2 | 290 |
| MRGPRE | QTGAL | Q67FW5 | 277 |
| MRGPRE | EFHB | Q8N7U6 | 276 |
| MRGPRE | CORT | O00230 | 275 |
| MRGPRE | GPR158 | Q5T848 | 264 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RAMP1 | MRGPRE | psi-mi:“MI:0915”(physical association) | 0.400 |
| MRGPRE | RAMP1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| MRGPRE | RAMP2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| RAMP2 | MRGPRE | psi-mi:“MI:0915”(physical association) | 0.400 |
| RAMP3 | MRGPRE | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (1): S (Reconstituted Complex)
ESM2 similar proteins: O75388, P04201, P12526, P23749, P30554, P35410, P59536, Q3UG50, Q3UG61, Q5U9D7, Q5Y4Z0, Q645U0, Q645Y3, Q645Z1, Q646B2, Q646C7, Q646E6, Q646F3, Q6L786, Q7TN38, Q7TN39, Q7TN40, Q7TN41, Q7TN44, Q7TN45, Q7TN50, Q7TN51, Q7TQA6, Q86SM5, Q86SM8, Q8CIP3, Q8NGA4, Q8R4G1, Q8TDS7, Q8VCJ6, Q91WW2, Q91WW3, Q91WW4, Q91ZB5, Q91ZB7
Diamond homologs: O55197, P04201, P12526, P23749, P30554, P35410, Q16581, Q2LL16, Q3KNA1, Q3UG50, Q3UG61, Q4QXU0, Q4QXU2, Q4QXU3, Q4QXU4, Q4QXU5, Q4QXU6, Q4QXX9, Q5REI5, Q5U9D7, Q5U9D9, Q6L786, Q6TAC8, Q7TN38, Q7TN39, Q7TN40, Q7TN41, Q7TN44, Q7TN45, Q7TN49, Q7TN50, Q7TN51, Q86SM5, Q86SM8, Q8CIP3, Q8NGA4, Q8R4G1, Q8TDS7, Q8TDT2, Q8VCJ6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
31 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 29 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
229 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:3228858:CCC:C | acceptor_gain | 1.0000 |
| 11:3228859:CC:C | acceptor_gain | 1.0000 |
| 11:3228859:CCC:C | acceptor_gain | 1.0000 |
| 11:3228860:CC:C | acceptor_gain | 1.0000 |
| 11:3228861:C:CC | acceptor_gain | 1.0000 |
| 11:3228861:CTGTA:C | acceptor_loss | 1.0000 |
| 11:3228862:T:G | acceptor_loss | 1.0000 |
| 11:3228856:TGCCC:T | acceptor_gain | 0.9900 |
| 11:3232136:CTCA:C | donor_loss | 0.9900 |
| 11:3232137:TCAC:T | donor_loss | 0.9900 |
| 11:3232138:CACC:C | donor_loss | 0.9900 |
| 11:3232139:A:AC | donor_gain | 0.9900 |
| 11:3232139:A:AT | donor_loss | 0.9900 |
| 11:3232139:AC:A | donor_gain | 0.9900 |
| 11:3232140:C:CA | donor_loss | 0.9900 |
| 11:3232140:C:CC | donor_gain | 0.9900 |
| 11:3232140:CC:C | donor_gain | 0.9900 |
| 11:3228857:GCCC:G | acceptor_gain | 0.9800 |
| 11:3228858:CCCC:C | acceptor_gain | 0.9800 |
| 11:3232140:CCG:C | donor_gain | 0.9800 |
| 11:3232140:CCGT:C | donor_gain | 0.9800 |
| 11:3228112:C:CT | acceptor_gain | 0.9700 |
| 11:3228869:C:CT | acceptor_gain | 0.9700 |
| 11:3232140:CCGTT:C | donor_gain | 0.9700 |
| 11:3232170:G:A | donor_gain | 0.9700 |
| 11:3228869:C:T | acceptor_gain | 0.9600 |
| 11:3232179:G:T | donor_gain | 0.8900 |
| 11:3228863:G:GC | acceptor_gain | 0.8700 |
| 11:3231257:A:C | acceptor_gain | 0.8400 |
| 11:3231909:A:AC | donor_gain | 0.8200 |
AlphaMissense
1980 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:3228038:G:C | S254R | 0.987 |
| 11:3228038:G:T | S254R | 0.987 |
| 11:3228040:T:G | S254R | 0.987 |
| 11:3228584:G:C | F72L | 0.979 |
| 11:3228584:G:T | F72L | 0.979 |
| 11:3228586:A:G | F72L | 0.979 |
| 11:3228484:A:G | C106R | 0.975 |
| 11:3228464:A:C | S112R | 0.974 |
| 11:3228464:A:T | S112R | 0.974 |
| 11:3228466:T:G | S112R | 0.974 |
| 11:3228580:C:G | G74R | 0.973 |
| 11:3228212:G:C | S196R | 0.969 |
| 11:3228212:G:T | S196R | 0.969 |
| 11:3228214:T:G | S196R | 0.969 |
| 11:3228577:A:G | C75R | 0.966 |
| 11:3228358:A:G | W148R | 0.959 |
| 11:3228358:A:T | W148R | 0.959 |
| 11:3228488:G:C | F104L | 0.958 |
| 11:3228488:G:T | F104L | 0.958 |
| 11:3228490:A:G | F104L | 0.958 |
| 11:3228674:A:C | N42K | 0.958 |
| 11:3228674:A:T | N42K | 0.958 |
| 11:3228122:G:C | F226L | 0.956 |
| 11:3228122:G:T | F226L | 0.956 |
| 11:3228124:A:G | F226L | 0.956 |
| 11:3228349:A:G | C151R | 0.955 |
| 11:3228506:G:C | S98R | 0.953 |
| 11:3228506:G:T | S98R | 0.953 |
| 11:3228508:T:G | S98R | 0.953 |
| 11:3228672:C:T | G43E | 0.953 |
dbSNP variants (sampled 300 via entrez): RS1000248344 (11:3227964 C>A,T), RS1000908550 (11:3231643 G>A), RS1001054068 (11:3232669 G>A), RS1001402656 (11:3227843 G>A,C,T), RS1001406903 (11:3234028 C>T), RS1001992092 (11:3225530 G>A), RS1002597734 (11:3230250 G>A), RS1002668931 (11:3231175 A>G), RS1003121909 (11:3230428 A>G), RS1003132378 (11:3229718 C>G), RS1003517912 (11:3231084 A>G), RS1003853023 (11:3229406 T>A), RS1003947887 (11:3229656 G>T), RS1005081190 (11:3225992 C>A,T), RS1005181786 (11:3229024 T>C)
Disease associations
OMIM: gene MIM:607232 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001860_1 | Multiple sclerosis | 2.000000e-06 |
| GCST010725_20 | Malaria | 4.000000e-69 |
| GCST010725_33 | Malaria | 2.000000e-67 |
| GCST010725_51 | Malaria | 1.000000e-55 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523882 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Class A Orphans with emerging pharmacology
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| tebuconazole | decreases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| abrine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Silicon Dioxide | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
ChEMBL screening assays
2 unique, capped per target: 2 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4883532 | Binding | PRESTO-Tango GPCRome screening (MRGPRE) | Data for DCP probe UCSF924 |
Cellosaurus cell lines
1 cell lines: 1 spontaneously immortalized cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_KY46 | PathHunter CHO-K1 MRGPRE beta-arrestin | Spontaneously immortalized cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.